Moy, Beverly
eCommons Login: BM7
first name: Beverly
last name: Moy
coauthor of: Spring, Laura
coauthor of: Medford, Arielle
coauthor of: Peppercorn, Jeffrey
coauthor of: Isakoff, Steven
coauthor of: Ellisen, Leif
full name: Beverly Moy, M.D.
has faculty rank: Full Professor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.36241700000000
longitude: -71.06893700000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 30867
person in primary position: Professor of Medicine
physical neighbor: Allen, Jill
physical neighbor: Blaszkowsky, Lawrence
physical neighbor: Brunner, Andrew
physical neighbor: Kuter, Irene
physical neighbor: Spitzer, Thomas
similar to: Tolaney, Sara
similar to: Winer, Eric
similar to: Partridge, Ann
similar to: Lin, Nancy
similar to: Mittendorf, Elizabeth
type: Agent
type: Person
selected publications: Authorship 1814589
selected publications: Authorship 1851164
selected publications: Authorship 1832471
selected publications: Authorship 1832079
selected publications: Authorship 1809883
selected publications: Authorship 1717070
selected publications: Authorship 1725766
selected publications: Authorship 1745819
selected publications: Authorship 1721964
selected publications: Authorship 1706190
selected publications: Authorship 1670432
selected publications: Authorship 1649320
selected publications: Authorship 1665197
selected publications: Authorship 1652065
selected publications: Authorship 1620570
selected publications: Authorship 1615517
selected publications: Authorship 1613239
selected publications: Authorship 1558192
selected publications: Authorship 1610231
selected publications: Authorship 1604725
selected publications: Authorship 1555717
selected publications: Authorship 1553795
selected publications: Authorship 1558603
selected publications: Authorship 1543366
selected publications: Authorship 1564234
selected publications: Authorship 1528178
selected publications: Authorship 1532284
selected publications: Authorship 1525545
selected publications: Authorship 1520149
selected publications: Authorship 1515805
selected publications: Authorship 1515842
selected publications: Authorship 1588859
selected publications: Authorship 1507626
selected publications: Authorship 1627434
selected publications: Authorship 1500233
selected publications: Authorship 1502422
selected publications: Authorship 1497186
selected publications: Authorship 1481664
selected publications: Authorship 1480375
selected publications: Authorship 1447231
selected publications: Authorship 1468707
selected publications: Authorship 1463758
selected publications: Authorship 1459195
selected publications: Authorship 1463819
selected publications: Authorship 1449949
selected publications: Authorship 1430257
selected publications: Authorship 1427151
selected publications: Authorship 1412658

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

Department
type: Class

Division
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Authorship 1045395
type: Authorship
author rank in publication: 17
linked author: Moy, Beverly
linked information resource: AR Expression in Breast Cancer CTCs Associates with Bone Metastases.

AR Expression in Breast Cancer CTCs Associates with Bone Metastases.
PubMed Identifier: 29453314
author list: Aceto N, Bardia A, Wittner BS, Donaldson MC, O'Keefe R, Engstrom A, Bersani F, Zheng Y, Comaills V, Niederhoffer K, Zhu H, Mackenzie O, Shioda T, Sgroi D, Kapur R, Ting DT, Moy B, Ramaswamy S, Toner M, Haber DA, Maheswaran S
published in: Molecular cancer research : MCR
information resource reference: AR Expression in Breast Cancer CTCs Associates with Bone Metastases. Mol Cancer Res. 2018 04; 16(4):720-727.
journal title abbreviation: Mol Cancer Res
publication date: 2018-02-16T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1055169
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act.

Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act.
PubMed Identifier: 29596618
author list: Nipp RD, Shui AM, Perez GK, Kirchhoff AC, Peppercorn JM, Moy B, Kuhlthau K, Park ER
published in: JAMA oncology
information resource reference: Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act. JAMA Oncol. 2018 06 01; 4(6):791-797.
journal title abbreviation: JAMA Oncol
publication date: 2018-06-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

TEACH: Tykerb evaluation after chemotherapy.
PubMed Identifier: 17386127
author list: Moy B, Goss PE
published in: Clinical breast cancer
information resource reference: TEACH: Tykerb evaluation after chemotherapy. Clin Breast Cancer. 2007 Feb; 7(6):489-92.
journal title abbreviation: Clin Breast Cancer
publication date: 2007-02-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Postmenopausal hormone use and symptoms of gastroesophageal reflux.
PubMed Identifier: 18779468
author list: Jacobson BC, Moy B, Colditz GA, Fuchs CS
published in: Archives of internal medicine
information resource reference: Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med. 2008 Sep 08; 168(16):1798-804.
journal title abbreviation: Arch Intern Med
publication date: 2008-09-08T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.
PubMed Identifier: 20084464
author list: Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E
published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
information resource reference: Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing. Qual Life Res. 2010 Apr; 19(3):401-12.
journal title abbreviation: Qual Life Res
publication date: 2010-04-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1063797
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Survivorship Model of Care: Development and Implementation of a Nurse Practitioner-Led Intervention for Patients With Breast Cancer?.

Survivorship Model of Care: Development and Implementation of a Nurse Practitioner-Led Intervention for Patients With Breast Cancer?.
PubMed Identifier: 28738044
author list: Post KE, Moy B, Furlani C, Strand E, Flanagan J, Peppercorn JM
published in: Clinical journal of oncology nursing
information resource reference: Survivorship Model of Care: Development and Implementation of a Nurse Practitioner-Led Intervention for Patients With Breast Cancer?. Clin J Oncol Nurs. 2017 Aug 01; 21(4):E99-E105.
journal title abbreviation: Clin J Oncol Nurs
publication date: 2017-08-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient navigator programs, cancer disparities, and the patient protection and affordable care act.
PubMed Identifier: 21804070
author list: Moy B, Chabner BA
published in: The oncologist
information resource reference: Patient navigator programs, cancer disparities, and the patient protection and affordable care act. Oncologist. 2011; 16(7):926-9.
journal title abbreviation: Oncologist
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Lapatinib.
PubMed Identifier: 17633789
author list: Moy B, Kirkpatrick P, Kar S, Goss P
published in: Nature reviews. Drug discovery
information resource reference: Lapatinib. Nat Rev Drug Discov. 2007 Jun; 6(6):431-2.
journal title abbreviation: Nat Rev Drug Discov
publication date: 2007-06-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
PubMed Identifier: 21810680
author list: Moy B, Polite BN, Halpern MT, Stranne SK, Winer EP, Wollins DS, Newman LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol. 2011 Oct 01; 29(28):3816-24.
journal title abbreviation: J Clin Oncol
publication date: 2011-08-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib.
PubMed Identifier: 21372222
author list: Morris PG, Chen C, Steingart R, Fleisher M, Lin N, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler M, McArthur HL, Winer E, Norton L, Hudis CA, Dang CT
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res. 2011 May 15; 17(10):3490-9.
journal title abbreviation: Clin Cancer Res
publication date: 2011-03-03T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1094489
type: Authorship
author rank in publication: 16
linked author: Moy, Beverly
linked information resource: Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.

Authorship 1094471
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement.

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.
PubMed Identifier: 30220055
author list: Spring L, Niemierko A, Haddad S, Yuen M, Comander A, Reynolds K, Shin J, Bahn A, Brachtel E, Specht M, Smith BL, Taghian A, Jimenez R, Peppercorn J, Isakoff SJ, Moy B, Bardia A
published in: Breast cancer research and treatment
information resource reference: Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer. Breast Cancer Res Treat. 2018 Dec; 172(3):733-740.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2018-09-15T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement.
PubMed Identifier: 30212297
author list: Winkfield KM, Phillips JK, Joffe S, Halpern MT, Wollins DS, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement. J Clin Oncol. 2018 Sep 13; JCO1801132.
journal title abbreviation: J Clin Oncol
publication date: 2018-09-13T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Mittendorf, Elizabeth
eCommons Login: EM285
first name: Elizabeth
last name: Mittendorf
full name: Elizabeth Mittendorf, M.D., Ph.D.
has faculty rank: Full Professor
Person ID: 172609
person in primary position: Professor of Surgery
type: Agent
type: Person
preferred title: Professor of Surgery

Lapatinib-associated toxicity and practical management recommendations.
PubMed Identifier: 17673607
author list: Moy B, Goss PE
published in: The oncologist
information resource reference: Lapatinib-associated toxicity and practical management recommendations. Oncologist. 2007 Jul; 12(7):756-65.
journal title abbreviation: Oncologist
publication date: 2007-07-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Mammographic breast density and race.
PubMed Identifier: 17377060
author list: del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS
published in: AJR. American journal of roentgenology
information resource reference: Mammographic breast density and race. AJR Am J Roentgenol. 2007 Apr; 188(4):1147-50.
journal title abbreviation: AJR Am J Roentgenol
publication date: 2007-04-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.
PubMed Identifier: 23015398
author list: Boutrus RR, Abi Raad RF, Kuter I, Ancukiewicz M, Roberts L, Solomon N, Ngo T, Borick H, Ryan P, Moy B, Gadd M, Chien J, Younger J, Smith B, Taghian AG, Harris L
published in: The International journal of biological markers
information resource reference: Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy. Int J Biol Markers. 2013 Apr 23; 28(1):17-23.
journal title abbreviation: Int J Biol Markers
publication date: 2013-04-23T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery.
PubMed Identifier: 22681763
author list: Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN
published in: BMC medical informatics and decision making
information resource reference: Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012 Jun 08; 12:51.
journal title abbreviation: BMC Med Inform Decis Mak
publication date: 2012-06-08T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1132006
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.

The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.
PubMed Identifier: 30753274
author list: Barroso-Sousa R, Barry WT, Guo H, Dillon D, Tan YB, Fuhrman K, Osmani W, Getz A, Baltay M, Dang C, Yardley D, Moy B, Marcom PK, Mittendorf EA, Krop IE, Winer EP, Tolaney SM
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial. Ann Oncol. 2019 04 01; 30(4):575-581.
journal title abbreviation: Ann Oncol
publication date: 2019-04-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 11761
type: Authorship
author rank in publication: 11
linked author: Moy, Beverly
linked information resource: Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

Authorship 1134616
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Authorship 1135234
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
PubMed Identifier: 30860945
author list: Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, Ibrahim N, Moynihan TJ, O'Sullivan CC, Nangia J, Niravath P, Tung N, Pohlmann PR, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. J Clin Oncol. 2019 05 01; 37(13):1081-1089.
journal title abbreviation: J Clin Oncol
publication date: 2019-03-12T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
PubMed Identifier: 30867034
author list: Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomaševic Z, Denduluri N, Šeparovic R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A
published in: Breast cancer research : BCR
information resource reference: PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial. Breast Cancer Res. 2019 03 11; 21(1):39.
journal title abbreviation: Breast Cancer Res
publication date: 2019-03-11T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Quinolines
MeSH DescriptorUI: D011804
MeSH semantic group name: Chemicals & Drugs
number of authors: 503
number of publications: 874
uniqueness weight: 0.627207
type: Concept

Breast Neoplasms
MeSH DescriptorUI: D001943
MeSH semantic group name: Disorders
number of authors: 2945
number of publications: 21232
uniqueness weight: 0.145907
type: Concept

Medical Oncology
MeSH DescriptorUI: D008495
MeSH semantic group name: Occupations
number of authors: 950
number of publications: 2515
uniqueness weight: 0.409812
type: Concept

Authorship 1142321
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).

Authorship 1144828
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Expanding Access to Cancer Clinical Trials for Patients With Mental Illness.

Authorship 1144826
type: Authorship
author rank in publication: 13
linked author: Moy, Beverly
linked information resource: Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Authorship 1147595
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.

Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
PubMed Identifier: 31004299
author list: Bellon JR, Guo H, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Hudis CA, Krop I, Burstein HJ, Winer EP, Tolaney SM
published in: Breast cancer research and treatment
information resource reference: Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Res Treat. 2019 Jul; 176(2):303-310.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2019-04-19T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Expanding Access to Cancer Clinical Trials for Patients With Mental Illness.
PubMed Identifier: 30986118
author list: Irwin KE, Moy B, Fields LE, Callaway CA, Park ER, Wirth L
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Expanding Access to Cancer Clinical Trials for Patients With Mental Illness. J Clin Oncol. 2019 06 20; 37(18):1524-1528.
journal title abbreviation: J Clin Oncol
publication date: 2019-04-15T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.
PubMed Identifier: 30988039
author list: Nipp RD, Lee H, Gorton E, Lichtenstein M, Kuchukhidze S, Park E, Chabner BA, Moy B
published in: The oncologist
information resource reference: Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention. Oncologist. 2019 08; 24(8):1048-1055.
journal title abbreviation: Oncologist
publication date: 2019-04-15T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
PubMed Identifier: 30939096
author list: Tolaney SM, Guo H, Pernas S, Barry WT, Dillon DA, Ritterhouse L, Schneider BP, Shen F, Fuhrman K, Baltay M, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer B, Partridge AH, Hudis CA, Krop IE, Burstein HJ, Winer EP
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. J Clin Oncol. 2019 08 01; 37(22):1868-1875.
journal title abbreviation: J Clin Oncol
publication date: 2019-04-02T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Neoplasms
MeSH DescriptorUI: D009369
MeSH semantic group name: Disorders
number of authors: 4708
number of publications: 23778
uniqueness weight: 0.125669
type: Concept

Antineoplastic Agents, Hormonal
MeSH DescriptorUI: D018931
MeSH semantic group name: Chemicals & Drugs
number of authors: 451
number of publications: 1505
uniqueness weight: 0.54837
type: Concept

Emeritus
type: Department
type: Organization

Medicine
type: Department
type: Organization

Surgery
type: Department
type: Organization

Hematology/Oncology
type: Division
type: Organization

Oncology
type: Division
type: Organization

Beth Israel Deaconess Medical Center
type: Organization

Dana-Farber Cancer Institute
type: Organization

Harvard Medical School
type: Organization

Massachusetts General Hospital
type: Organization

Lin, Nancy
eCommons Login: NUL1
first name: Nancy
last name: Lin
full name: Nancy U. Lin, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 33284
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Partridge, Ann
eCommons Login: AHP1
first name: Ann
last name: Partridge
full name: Ann Hart Partridge, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 84598
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Spitzer, Thomas
eCommons Login: TRS1
first name: Thomas
last name: Spitzer
full name: Thomas Richard Spitzer, M.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 66690
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 189
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 3.46197
minimum weight: 0.00173068
number of connections: 398
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 4.4236
minimum weight: 0.0150459
number of connections: 152
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 155.394
minimum weight: 21.3124
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Authorship 136865
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Postmenopausal hormone use and symptoms of gastroesophageal reflux.

Ellisen, Leif
eCommons Login: LWE1
first name: Leif
last name: Ellisen
full name: Leif William Ellisen, M.D.,Ph.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 53367
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Brunner, Andrew
eCommons Login: AMB55
first name: Andrew
last name: Brunner
full name: Andrew Mark Brunner, M.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 90021
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Isakoff, Steven
eCommons Login: SJI1
first name: Steven
last name: Isakoff
full name: Steven Jay Isakoff, M.D., Ph.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 3191
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Spring, Laura
eCommons Login: LMS36
first name: Laura
last name: Spring
full name: Laura M Spring, M.D.
has faculty rank: Assistant Professor
Person ID: 42390
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Kuter, Irene
eCommons Login: IK10
first name: Irene
last name: Kuter
full name: Irene Kuter, D.Phil., M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 7123
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Winer, Eric
eCommons Login: EPW2
first name: Eric
last name: Winer
full name: Eric Paul Winer, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 5538
person in primary position: Professor of Medicine, Emeritus
type: Agent
type: Person
preferred title: Professor of Medicine, Emeritus

Tolaney, Sara
eCommons Login: SMT9
first name: Sara
last name: Tolaney
full name: Sara Michell Tolaney, M.D.
has faculty rank: Associate Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 67909
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Allen, Jill
eCommons Login: JA48
first name: Jill
last name: Allen
full name: Jill Allen, M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 35695
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Blaszkowsky, Lawrence
eCommons Login: LSB7
first name: Lawrence
last name: Blaszkowsky
full name: Lawrence Scott Blaszkowsky, M.D.
has faculty rank: Instructor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 73258
person in primary position: Instructor in Medicine
type: Agent
type: Person
preferred title: Instructor in Medicine

Authorship 1174480
type: Authorship
author rank in publication: 18
linked author: Moy, Beverly
linked information resource: Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
PubMed Identifier: 31341951
author list: Medford AJ, Dubash TD, Juric D, Spring L, Niemierko A, Vidula N, Peppercorn J, Isakoff S, Reeves BA, LiCausi JA, Wesley B, Malvarosa G, Yuen M, Wittner BS, Lawrence MS, Iafrate AJ, Ellisen L, Moy B, Toner M, Maheswaran S, Haber DA, Bardia A
published in: NPJ precision oncology
information resource reference: Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer. NPJ Precis Oncol. 2019; 3:18.
journal title abbreviation: NPJ Precis Oncol
publication date: 2019-07-16T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1177693
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients.

Authorship 1177676
type: Authorship
author rank in publication: 15
linked author: Moy, Beverly
linked information resource: FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.
PubMed Identifier: 31371343
author list: Drago JZ, Formisano L, Juric D, Niemierko A, Servetto A, Wander SA, Spring LM, Vidula N, Younger J, Peppercorn J, Yuen M, Malvarosa G, Sgroi D, Isakoff SJ, Moy B, Ellisen LW, Iafrate AJ, Arteaga CL, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer. Clin Cancer Res. 2019 11 01; 25(21):6443-6451.
journal title abbreviation: Clin Cancer Res
publication date: 2019-08-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients.
PubMed Identifier: 31354095
author list: Sepucha KR, Langford AT, Belkora JK, Chang Y, Moy B, Partridge AH, Lee CN
published in: Medical decision making : an international journal of the Society for Medical Decision Making
information resource reference: Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients. Med Decis Making. 2019 08; 39(6):642-650.
journal title abbreviation: Med Decis Making
publication date: 2019-07-29T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1183177
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study.

Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study.
PubMed Identifier: 31449680
author list: Freund KM, Haas JS, Lemon SC, Burns White K, Casanova N, Dominici LS, Erban JK, Freedman RA, James TA, Ko NY, LeClair AM, Moy B, Parsons SK, Battaglia TA
published in: Cancer
information resource reference: Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study. Cancer. 2019 12 15; 125(24):4532-4540.
journal title abbreviation: Cancer
publication date: 2019-08-26T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1192262
type: Authorship
author rank in publication: 16
linked author: Moy, Beverly
linked information resource: Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
PubMed Identifier: 31558424
author list: Freedman RA, Gelman RS, Agar NYR, Santagata S, Randall EC, Gimenez-Cassina Lopez B, Connolly RM, Dunn IF, Van Poznak CH, Anders CK, Melisko ME, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Moy B, Blackwell KL, Puhalla SL, Ibrahim N, Moynihan TJ, Nangia J, Tung N, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU
published in: Clinical breast cancer
information resource reference: Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2.
journal title abbreviation: Clin Breast Cancer
publication date: 2019-08-22T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Massachusetts General Hospital

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Massachusetts General Hospital

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Massachusetts General Hospital

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Massachusetts General Hospital

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Massachusetts General Hospital

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Massachusetts General Hospital

Instructor in Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Instructor in Medicine
position in organization: Massachusetts General Hospital

Authorship 139977
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Mammographic breast density and race.

Authorship 11507
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Massachusetts General Hospital

Authorship 1226942
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.

Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.
PubMed Identifier: 32046998
author list: Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. Clin Cancer Res. 2020 06 15; 26(12):2838-2848.
journal title abbreviation: Clin Cancer Res
publication date: 2020-02-11T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1234122
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.

Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.
PubMed Identifier: 32145796
author list: Spring LM, Wander SA, Andre F, Moy B, Turner NC, Bardia A
published in: Lancet (London, England)
information resource reference: Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future. Lancet. 2020 03 07; 395(10226):817-827.
journal title abbreviation: Lancet
publication date: 2020-03-07T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.
PubMed Identifier: 32326897
author list: McCarthy AM, Kumar NP, He W, Regan S, Welch M, Moy B, Iafrate AJ, Chan AT, Bardia A, Armstrong K
published in: BMC cancer
information resource reference: Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer. BMC Cancer. 2020 Apr 23; 20(1):347.
journal title abbreviation: BMC Cancer
publication date: 2020-04-23T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1241094
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.

Authorship 129679
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].

Authorship 1252654
type: Authorship
author rank in publication: 26
linked author: Moy, Beverly
linked information resource: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
PubMed Identifier: 32483359
author list: Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ
published in: Nature medicine
information resource reference: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 08; 26(8):1280-1284.
journal title abbreviation: Nat Med
publication date: 2020-06-02T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1256589
type: Authorship
author rank in publication: 26
linked author: Moy, Beverly
linked information resource: Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
PubMed Identifier: 32555425
author list: Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ
published in: Nature medicine
information resource reference: Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 Aug; 26(8):1309.
journal title abbreviation: Nat Med
publication date: 2020-08-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1260179
type: Authorship
author rank in publication: 18
linked author: Moy, Beverly
linked information resource: Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer.

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer.
PubMed Identifier: 32571788
author list: Vidula N, Dubash T, Lawrence MS, Simoneau A, Niemierko A, Blouch E, Nagy B, Roh W, Chirn B, Reeves BA, Malvarosa G, Lennerz J, Isakoff SJ, Juric D, Micalizzi D, Wander S, Spring L, Moy B, Shannon K, Younger J, Lanman R, Toner M, Iafrate AJ, Getz G, Zou L, Ellisen LW, Maheswaran S, Haber DA, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer. Clin Cancer Res. 2020 09 15; 26(18):4852-4862.
journal title abbreviation: Clin Cancer Res
publication date: 2020-06-22T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1261683
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.
PubMed Identifier: 32610007
author list: Spring LM, Specht MC, Jimenez RB, Isakoff SJ, Wang GX, Ly A, Shin JA, Bardia A, Moy B
published in: The New England journal of medicine
information resource reference: Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic. N Engl J Med. 2020 Jul 16; 383(3):262-272.
journal title abbreviation: N Engl J Med
publication date: 2020-07-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1270519
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With = 2 HER2-Directed Regimens: Phase III NALA Trial.

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With = 2 HER2-Directed Regimens: Phase III NALA Trial.
PubMed Identifier: 32678716
author list: Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With = 2 HER2-Directed Regimens: Phase III NALA Trial. J Clin Oncol. 2020 09 20; 38(27):3138-3149.
journal title abbreviation: J Clin Oncol
publication date: 2020-07-17T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1271142
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry.

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry.
PubMed Identifier: 32712878
author list: Smith BL, Nguyen A, Korotkin JE, Kelly BN, Specht MC, Spring LM, Moy B, Isakoff SJ, Gadd MA
published in: Breast cancer research and treatment
information resource reference: A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry. Breast Cancer Res Treat. 2020 Oct; 183(3):515-524.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2020-07-25T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1276582
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.

Authorship 1277214
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.

Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
PubMed Identifier: 32807644
author list: McDonough AL, Lei Y, Kwak AH, Haggett DE, Jimenez RB, Johnston KT, Moy B, Spring LM, Peppercorn J
published in: Clinical breast cancer
information resource reference: Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors. Clin Breast Cancer. 2021 02; 21(1):e88-e95.
journal title abbreviation: Clin Breast Cancer
publication date: 2020-07-15T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.
PubMed Identifier: 32799886
author list: Yang DD, Buscariollo DL, Cronin AM, Weng S, Hughes ME, Bleicher RJ, Cohen AL, Javid SH, Edge SB, Moy B, Niland JC, Wolff AC, Hassett MJ, Punglia RS
published in: Radiation oncology (London, England)
information resource reference: Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer. Radiat Oncol. 2020 Aug 17; 15(1):198.
journal title abbreviation: Radiat Oncol
publication date: 2020-08-17T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 190447
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Is there a role for decision aids in advanced breast cancer?

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1305469
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Authorship 1305102
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population.

The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population.
PubMed Identifier: 33153384
author list: Beyerlin K, Jimenez R, Zangardi M, Fell GG, Edmonds C, Johnson A, Bossuyt V, Specht M, Mulvey TM, Moy B, Ellisen LW, Isakoff SJ, Bardia A, Spring LM
published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
information resource reference: The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. J Oncol Pharm Pract. 2021 Dec; 27(8):1883-1890.
journal title abbreviation: J Oncol Pharm Pract
publication date: 2020-11-05T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
PubMed Identifier: 33183970
author list: Chan A, Moy B, Mansi J, Ejlertsen B, Holmes FA, Chia S, Iwata H, Gnant M, Loibl S, Barrios CH, Somali I, Smichkoska S, Martinez N, Alonso MG, Link JS, Mayer IA, Cold S, Murillo SM, Senecal F, Inoue K, Ruiz-Borrego M, Hui R, Denduluri N, Patt D, Rugo HS, Johnston SRD, Bryce R, Zhang B, Xu F, Wong A, Martin M
published in: Clinical breast cancer
information resource reference: Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial. Clin Breast Cancer. 2021 02; 21(1):80-91.e7.
journal title abbreviation: Clin Breast Cancer
publication date: 2020-10-06T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1323890
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.

Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.
PubMed Identifier: 33504549
author list: Vidula N, Niemierko A, Malvarosa G, Yuen M, Lennerz J, Iafrate AJ, Wander SA, Spring L, Juric D, Isakoff S, Younger J, Moy B, Ellisen LW, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer. Clin Cancer Res. 2021 06 15; 27(12):3404-3413.
journal title abbreviation: Clin Cancer Res
publication date: 2021-01-27T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1338203
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study.

Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study.
PubMed Identifier: 33691275
author list: Asad S, Barcenas CH, Bleicher RJ, Cohen AL, Javid SH, Levine EG, Lin NU, Moy B, Niland J, Wolff AC, Hassett MJ, Stover DG
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study. J Natl Compr Canc Netw. 2021 03 10; 19(7):797-804.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2021-03-10T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1342361
type: Authorship
author rank in publication: 19
linked author: Moy, Beverly
linked information resource: Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
PubMed Identifier: 33761455
author list: Wander SA, Han HS, Zangardi ML, Niemierko A, Mariotti V, Kim LSL, Xi J, Pandey A, Dunne S, Nasrazadani A, Kambadakone A, Stein C, Lloyd MR, Yuen M, Spring LM, Juric D, Kuter I, Sanidas I, Moy B, Mulvey T, Vidula N, Dyson NJ, Ellisen LW, Isakoff S, Wagle N, Brufsky A, Kalinsky K, Ma CX, O'Shaughnessy J, Bardia A
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience. J Natl Compr Canc Netw. 2021 Mar 24; 1-8.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2021-03-24T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1347113
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Neratinib?+?capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and?=?2 prior HER2-directed regimens.

Neratinib?+?capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and?=?2 prior HER2-directed regimens.
PubMed Identifier: 33909203
author list: Moy B, Oliveira M, Saura C, Gradishar W, Kim SB, Brufsky A, Hurvitz SA, Ryvo L, Fagnani D, Kalmadi S, Silverman P, Delaloge S, Alarcon J, Kwong A, Lee KS, Ang PCS, Ow SGW, Chu SC, Bryce R, Keyvanjah K, Bebchuk J, Zhang B, Oestreicher N, Bose R, Chan N
published in: Breast cancer research and treatment
information resource reference: Neratinib?+?capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and?=?2 prior HER2-directed regimens. Breast Cancer Res Treat. 2021 Jul; 188(2):449-458.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2021-04-28T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1359260
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
PubMed Identifier: 34028126
author list: Hurvitz SA, Saura C, Oliveira M, Trudeau ME, Moy B, Delaloge S, Gradishar W, Kim SB, Haley B, Ryvo L, Dai MS, Milovanov V, Alarcón J, Kalmadi S, Cronemberger E, Souza C, Landeiro L, Bose R, Bebchuk J, Kabbinavar F, Bryce R, Keyvanjah K, Brufsky AM
published in: The oncologist
information resource reference: Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial. Oncologist. 2021 08; 26(8):e1327-e1338.
journal title abbreviation: Oncologist
publication date: 2021-06-07T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1373252
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities.

Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities.
PubMed Identifier: 34176192
author list: Spring LM, Nakajima E, Hutchinson J, Viscosi E, Blouin G, Weekes C, Rugo H, Moy B, Bardia A
published in: The oncologist
information resource reference: Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities. Oncologist. 2021 10; 26(10):827-834.
journal title abbreviation: Oncologist
publication date: 2021-07-10T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1380043
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/183720213

https://connects.catalyst.harvard.edu/Profiles/profile/183720213
PubMed Identifier: 34324366
author list: Moy B, Rumble RB, Come SE, Davidson NE, Di Leo A, Gralow JR, Hortobagyi GN, Yee D, Smith IE, Chavez-MacGregor M, Nanda R, McArthur HL, Spring L, Reeder-Hayes KE, Ruddy KJ, Unger PS, Vinayak S, Irvin WJ, Armaghani A, Danso MA, Dickson N, Turner SS, Perkins CL, Carey LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol. 2021 12 10; 39(35):3938-3958.
journal title abbreviation: J Clin Oncol
publication date: 2021-07-29T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Authorship 1381633
type: Authorship
author rank in publication: 11
linked author: Moy, Beverly
linked information resource: Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.
PubMed Identifier: 34349115
author list: Spring LM, Clark SL, Li T, Goel S, Tayob N, Viscosi E, Abraham E, Juric D, Isakoff SJ, Mayer E, Moy B, Supko JG, Tolaney SM, Bardia A
published in: NPJ breast cancer
information resource reference: Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer. NPJ Breast Cancer. 2021 Aug 04; 7(1):103.
journal title abbreviation: NPJ Breast Cancer
publication date: 2021-08-04T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1384273
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Disparities in phase 1 cancer clinical trial enrollment.

Authorship 1384800
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.

Disparities in phase 1 cancer clinical trial enrollment.
PubMed Identifier: 34379799
author list: Perni S, Moy B, Nipp RD
published in: Cancer
information resource reference: Disparities in phase 1 cancer clinical trial enrollment. Cancer. 2021 Dec 01; 127(23):4464-4469.
journal title abbreviation: Cancer
publication date: 2021-08-11T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.
PubMed Identifier: 34380637
author list: Saura C, Matito J, Oliveira M, Wildiers H, Brufksy AM, Waters SH, Hurvitz SA, Moy B, Kim SB, Gradishar WJ, Queiroz GS, Cronemberger E, Wallweber GJ, Bebchuk J, Keyvanjah K, Lalani AS, Bryce R, Vivancos A, Eli LD, Delaloge S
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer. Clin Cancer Res. 2021 11 01; 27(21):5818-5827.
journal title abbreviation: Clin Cancer Res
publication date: 2021-08-11T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 18197
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Patient navigator programs, cancer disparities, and the patient protection and affordable care act.

Authorship 188379
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Doctor-patient communication about advance directives in metastatic breast cancer.

Authorship 1403240
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Antibody drug conjugates for patients with breast cancer.

Antibody drug conjugates for patients with breast cancer.
PubMed Identifier: 34635342
author list: Medford A, Spring LM, Moy B, Bardia A
published in: Current problems in cancer
information resource reference: Antibody drug conjugates for patients with breast cancer. Curr Probl Cancer. 2021 10; 45(5):100795.
journal title abbreviation: Curr Probl Cancer
publication date: 2021-10-04T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1412658
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Assessment of patient navigation programs for breast cancer patients across the city of Boston.

Assessment of patient navigation programs for breast cancer patients across the city of Boston.
PubMed Identifier: 34767089
author list: LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2022 Mar; 30(3):2435-2443.
journal title abbreviation: Support Care Cancer
publication date: 2021-11-12T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer.
PubMed Identifier: 35050782
author list: Velimirovic M, Juric D, Niemierko A, Spring L, Vidula N, Wander SA, Medford A, Parikh A, Malvarosa G, Yuen M, Corcoran R, Moy B, Isakoff SJ, Ellisen LW, Iafrate A, Chabner B, Bardia A
published in: JCO precision oncology
information resource reference: Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer. JCO Precis Oncol. 2020 Nov; 4:1246-1262.
journal title abbreviation: JCO Precis Oncol
publication date: 2020-11-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
PubMed Identifier: 35041467
author list: Eisen A, Somerfield MR, Accordino MK, Blanchette PS, Clemons MJ, Dhesy-Thind S, Dillmon MS, D'Oronzo S, Fletcher GG, Frank ES, Hallmeyer S, Makhoul I, Moy B, Thawer A, Wu JY, Van Poznak CH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. J Clin Oncol. 2022 03 01; 40(7):787-800.
journal title abbreviation: J Clin Oncol
publication date: 2022-01-18T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1427151
type: Authorship
author rank in publication: 13
linked author: Moy, Beverly
linked information resource: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.

Authorship 1426856
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer.

Authorship 166271
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Institutional academic industry relationship: results of interviews with university leaders.

Authorship 1430257
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic Breast Cancer.

Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic Breast Cancer.
PubMed Identifier: 35130492
author list: Greer JA, Moy B, El-Jawahri A, Jackson VA, Kamdar M, Jacobsen J, Lindvall C, Shin JA, Rinaldi S, Carlson HA, Sousa A, Gallagher ER, Li Z, Moran S, Ruddy M, Anand MV, Carp JE, Temel JS
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic Breast Cancer. J Natl Compr Canc Netw. 2022 02; 20(2):136-143.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2022-02-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1449949
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast).

Authorship 1447231
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.

Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.
PubMed Identifier: 35443045
author list: Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B
published in: The oncologist
information resource reference: Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 07 05; 27(7):518-524.
journal title abbreviation: Oncologist
publication date: 2022-07-05T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast).
PubMed Identifier: 35441995
author list: O'Donnell E, Shapiro Y, Comander A, Isakoff S, Moy B, Spring L, Wander S, Kuter I, Shin J, Specht M, Kournioti C, Hu B, Sullivan C, Winters L, Horick N, Peppercorn J
published in: Breast cancer research and treatment
information resource reference: Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast). Breast Cancer Res Treat. 2022 Jun; 193(3):579-587.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2022-04-20T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1459195
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.

Authorship 1468707
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Enhancing Health Equity Through Cancer Health Economics Research.

Authorship 1463819
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants.

Authorship 1463758
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update.

Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.
PubMed Identifier: 35715538
author list: Sella T, Exman P, Ren S, Freret TS, Economy KE, Chen WY, Parsons HA, Lin NU, Moy B, Tung NM, Partridge AH, Tayob N, Mayer EL
published in: Breast cancer research and treatment
information resource reference: Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2022 Aug; 194(3):597-606.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2022-06-17T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Enhancing Health Equity Through Cancer Health Economics Research.
PubMed Identifier: 35788369
author list: Bradley CJ, Simon K, Winkfield K, Moy B
published in: Journal of the National Cancer Institute. Monographs
information resource reference: Enhancing Health Equity Through Cancer Health Economics Research. J Natl Cancer Inst Monogr. 2022 07 05; 2022(59):74-78.
journal title abbreviation: J Natl Cancer Inst Monogr
publication date: 2022-07-05T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants.
PubMed Identifier: 35666957
author list: Perni S, Azoba C, Gorton E, Park ER, Chabner BA, Moy B, Nipp RD
published in: JCO oncology practice
information resource reference: Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants. JCO Oncol Pract. 2022 09; 18(9):e1427-e1437.
journal title abbreviation: JCO Oncol Pract
publication date: 2022-06-06T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update.
PubMed Identifier: 35759724
author list: Henry NL, Somerfield MR, Dayao Z, Elias A, Kalinsky K, McShane LM, Moy B, Park BH, Shanahan KM, Sharma P, Shatsky R, Stringer-Reasor E, Telli M, Turner NC, DeMichele A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2022 09 20; 40(27):3205-3221.
journal title abbreviation: J Clin Oncol
publication date: 2022-06-27T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 39429
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Hemolytic uremic syndrome associated with clopidogrel: a case report.

Authorship 1480375
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/203401354

Authorship 1500233
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer.

Authorship 1497186
type: Authorship
author rank in publication: 17
linked author: Moy, Beverly
linked information resource: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.

Authorship 1502422
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.

Authorship 1481664
type: Authorship
author rank in publication: 26
linked author: Moy, Beverly
linked information resource: Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.

Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
PubMed Identifier: 36220724
author list: Hendrix N, Oestreicher N, Lalla D, Dolan CM, Fisher KA, Veenstra DL, Moy B
published in: Clinical breast cancer
information resource reference: Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model. Clin Breast Cancer. 2022 12; 22(8):781-791.
journal title abbreviation: Clin Breast Cancer
publication date: 2022-09-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/203401354
PubMed Identifier: 35926153
author list: Moy B, Rumble RB, Carey LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2022 09 10; 40(26):3088-3090.
journal title abbreviation: J Clin Oncol
publication date: 2022-08-04T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update.

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
PubMed Identifier: 36051470
author list: Denault E, Nakajima E, Naranbhai V, Hutchinson JA, Mortensen L, Neihoff E, Barabell C, Comander A, Juric D, Kuter I, Mulvey T, Peppercorn J, Rosenstock AS, Shin J, Vidula N, Wander SA, Moy B, Ellisen LW, Isakoff SJ, Iafrate AJ, Gainor JF, Bardia A, Spring LM
published in: Therapeutic advances in medical oncology
information resource reference: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221119370.
journal title abbreviation: Ther Adv Med Oncol
publication date: 2022-08-22T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
PubMed Identifier: 35962750
author list: Shuman AG, Aapro MS, Anderson B, Arbour K, Barata PC, Bardia A, Bruera E, Chabner BA, Chen H, Choy E, Conte P, Curigliano G, Dizon D, O'Reilly E, Tito Fojo A, Gelderblom H, Graubert TA, Gurtler JS, Hall E, Hirsch FR, Idbaih A, Ilson DH, Kelley M, La Vecchia C, Ludwig H, Moy B, Muss H, Opdam F, Pentz RD, Posner MR, Ross JS, Sacher A, Senan S, Perez de Celis ES, Tanabe KK, Vermorken JB, Wehrenberg-Klee E, Bates SE
published in: The oncologist
information resource reference: Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization. Oncologist. 2022 Aug 13.
journal title abbreviation: Oncologist
publication date: 2022-08-13T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer.
PubMed Identifier: 36138293
author list: McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K
published in: Breast cancer research and treatment
information resource reference: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Res Treat. 2022 Nov; 196(2):389-398.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2022-09-22T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1507626
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.

Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.
PubMed Identifier: 36455189
author list: Sedrak MS, Sun CL, Ji J, Cohen HJ, Gross CP, Tew WP, Klepin HD, Wildes TM, Dotan E, Freedman RA, O'Connor T, Chow S, Fenton MA, Moy B, Chapman AE, Dale W, Katheria V, Kuderer NM, Lyman GH, Magnuson A, Muss HB
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. J Clin Oncol. 2023 01 10; 41(2):316-326.
journal title abbreviation: J Clin Oncol
publication date: 2022-12-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 197397
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: TEACH: Tykerb evaluation after chemotherapy.

Authorship 1515805
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.

Authorship 1515842
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update.

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update.
PubMed Identifier: 36626701
author list: Moy B, Rumble RB, Carey LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2023 02 20; 41(6):1318-1320.
journal title abbreviation: J Clin Oncol
publication date: 2023-01-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
PubMed Identifier: 36643653
author list: McLaughlin S, Nakajima E, Bar Y, Hutchinson JA, Shin J, Moy B, Isakoff SJ, Bardia A, Kuter I, Spring LM
published in: Therapeutic advances in medical oncology
information resource reference: Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer. Ther Adv Med Oncol. 2023; 15:17588359221146133.
journal title abbreviation: Ther Adv Med Oncol
publication date: 2023-01-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1520149
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study.

Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study.
PubMed Identifier: 36681001
author list: Abraham A, Barcenas CH, Bleicher RJ, Cohen AL, Javid SH, Levine EG, Lin NU, Moy B, Niland JC, Wolff AC, Hassett MJ, Asad S, Stover DG
published in: Breast (Edinburgh, Scotland)
information resource reference: Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study. Breast. 2023 Feb; 67:89-93.
journal title abbreviation: Breast
publication date: 2023-01-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1525545
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
PubMed Identifier: 36743521
author list: Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, Dai CS, Gogakos T, Keenan JC, Occhiogrosso RH, Ryan P, Lennerz JK, Spring LM, Moy B, Ellisen LW, Bardia A
published in: Therapeutic advances in medical oncology
information resource reference: TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023; 15:17588359231152844.
journal title abbreviation: Ther Adv Med Oncol
publication date: 2023-01-30T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1528178
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
PubMed Identifier: 36858723
author list: Tolaney SM, Tarantino P, Graham N, Tayob N, Parè L, Villacampa G, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Barroso-Sousa R, Villagrasa P, DeMeo M, DiLullo M, Zanudo JGT, Weiss J, Wagle N, Partridge AH, Waks AG, Hudis CA, Krop IE, Burstein HJ, Prat A, Winer EP
published in: The Lancet. Oncology
information resource reference: Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Lancet Oncol. 2023 03; 24(3):273-285.
journal title abbreviation: Lancet Oncol
publication date: 2023-03-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1532284
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
PubMed Identifier: 36898233
author list: Holmes FA, Moy B, Delaloge S, Chia SKL, Ejlertsen B, Mansi J, Iwata H, Gnant M, Buyse M, Barrios CH, Silovski T, Šeparovic R, Bashford A, Zotano AG, Denduluri N, Patt D, Gokmen E, Gore I, Smith JW, Loibl S, Masuda N, Tomaševic Z, Petráková K, DiPrimeo D, Wong A, Martin M, Chan A
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial. Eur J Cancer. 2023 05; 184:48-59.
journal title abbreviation: Eur J Cancer
publication date: 2023-02-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Massachusetts General Hospital

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
PubMed Identifier: 37141550
author list: Brett JO, Dubash TD, Johnson GN, Niemierko A, Mariotti V, Kim LSL, Xi J, Pandey A, Dunne S, Nasrazadani A, Lloyd MR, Kambadakone A, Spring LM, Micalizzi DS, Onozato ML, Che D, Nayar U, Brufsky A, Kalinsky K, Ma CX, O'Shaughnessy J, Han HS, Iafrate AJ, Ryan LY, Juric D, Moy B, Ellisen LW, Maheswaran S, Wagle N, Haber DA, Bardia A, Wander SA
published in: JCO precision oncology
information resource reference: A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO Precis Oncol. 2023 05; 7:e2200532.
journal title abbreviation: JCO Precis Oncol
publication date: 2023-05-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1558192
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception.

Authorship 1555717
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Circulating Tumor DNA in Breast Cancer: Current and Future Applications.

Authorship 1543366
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study).

Authorship 1558603
type: Authorship
author rank in publication: 26
linked author: Moy, Beverly
linked information resource: A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.

Authorship 1553795
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/215503042

Authorship 1564234
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.

https://connects.catalyst.harvard.edu/Profiles/profile/215503042
PubMed Identifier: 37284796
author list: Moy B, Wolff AC, Rumble RB, Allison KH, Carey LA
published in: JCO oncology practice
information resource reference: Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A. JCO Oncol Pract. 2023 08; 19(8):547-550.
journal title abbreviation: JCO Oncol Pract
publication date: 2023-06-07T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.

Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.
PubMed Identifier: 37076495
author list: Vidula N, Niemierko A, Hesler K, Ryan L, Moy B, Isakoff S, Ellisen L, Juric D, Bardia A
published in: NPJ breast cancer
information resource reference: Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer. NPJ Breast Cancer. 2023 Apr 19; 9(1):29.
journal title abbreviation: NPJ Breast Cancer
publication date: 2023-04-19T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception.
PubMed Identifier: 37477704
author list: Medford AJ, Moy B, Spring LM, Hurvitz SA, Turner NC, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception. Clin Cancer Res. 2023 11 14; 29(22):4540-4548.
journal title abbreviation: Clin Cancer Res
publication date: 2023-11-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study).
PubMed Identifier: 37103597
author list: Isakoff SJ, Said MR, Kwak AH, Glieberman E, O'Rourke EA, Stroiney A, Spring LM, Moy B, Bardia A, Horick N, Peppercorn JM
published in: Breast cancer research and treatment
information resource reference: Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study). Breast Cancer Res Treat. 2023 Jun; 199(3):501-509.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2023-04-27T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.
PubMed Identifier: 37438196
author list: Medford AJ, Denault EN, Moy B, Parsons HA, Bardia A
published in: Clinical breast cancer
information resource reference: Circulating Tumor DNA in Breast Cancer: Current and Future Applications. Clin Breast Cancer. 2023 10; 23(7):687-692.
journal title abbreviation: Clin Breast Cancer
publication date: 2023-06-20T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1588859
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.

Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.
PubMed Identifier: 37724824
author list: Perez GK, Oberoi AR, Finkelstein-Fox L, Park ER, Nipp RD, Moy B
published in: Cancer control : journal of the Moffitt Cancer Center
information resource reference: Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations. Cancer Control. 2023 Jan-Dec; 30:10732748231187829.
journal title abbreviation: Cancer Control
publication date: 2023-01-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 395899
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.

Authorship 426361
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.

Authorship 1604725
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.
PubMed Identifier: 37922440
author list: Spring LM, Mortensen L, Abraham E, Keenan J, Medford A, Ma A, Padden S, Denault E, Ryan L, Iafrate AJ, Lennerz J, Hochberg E, Wander SA, Moy B, Isakoff SJ, Juric D, Brennan KA, Smith DE, Civiello B, Mulvey T, Comander A, Ellisen LW, Schwartz JH, Bardia A
published in: JCO oncology practice
information resource reference: Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration. JCO Oncol Pract. 2024 01; 20(1):69-76.
journal title abbreviation: JCO Oncol Pract
publication date: 2023-11-03T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1610231
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.

Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
PubMed Identifier: 37962093
author list: Ji J, Bae M, Sun CL, Wildes TM, Freedman RA, Magnuson A, O'Connor T, Moy B, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Gross CP, Cohen HJ, Muss HB, Sedrak MS
published in: Cancer
information resource reference: Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial. Cancer. 2024 03 15; 130(6):936-946.
journal title abbreviation: Cancer
publication date: 2023-11-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1615517
type: Authorship
author rank in publication: 18
linked author: Moy, Beverly
linked information resource: Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Authorship 1613239
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages.

ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages.
PubMed Identifier: 38061010
author list: Hantel A, Spence R, Camacho P, Bradbury AR, Denburg AE, Jagsi R, Moy B, Rathmell WK, Rosenberg AR, Symington B, Marron JM, Peppercorn J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages. J Clin Oncol. 2024 Jan 20; 42(3):358-365.
journal title abbreviation: J Clin Oncol
publication date: 2023-12-07T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.
PubMed Identifier: 38092228
author list: Spring LM, Tolaney SM, Fell G, Bossuyt V, Abelman RO, Wu B, Maheswaran S, Trippa L, Comander A, Mulvey T, McLaughlin S, Ryan P, Ryan L, Abraham E, Rosenstock A, Garrido-Castro AC, Lynce F, Moy B, Isakoff SJ, Tung N, Mittendorf EA, Ellisen LW, Bardia A
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial. Ann Oncol. 2024 Mar; 35(3):293-301.
journal title abbreviation: Ann Oncol
publication date: 2023-12-12T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1620570
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.

Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.
PubMed Identifier: 38206277
author list: Al Sukhun S, Temin S, Barrios CH, Antone NZ, Guerra YC, Chavez-MacGregor M, Chopra R, Danso MA, Gomez HL, Homian NM, Kandil A, Kithaka B, Koczwara B, Moy B, Nakigudde G, Petracci FE, Rugo HS, El Saghir NS, Arun BK
published in: JCO global oncology
information resource reference: Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO Glob Oncol. 2024 01; 10:e2300285.
journal title abbreviation: JCO Glob Oncol
publication date: 2024-01-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1627434
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Bone-Modifying Agents in Early Breast Cancer: Making Sense of Conflicting Data.

Bone-Modifying Agents in Early Breast Cancer: Making Sense of Conflicting Data.
PubMed Identifier: 38319831
author list: Warner ET, Moy B
published in: NEJM evidence
information resource reference: Bone-Modifying Agents in Early Breast Cancer: Making Sense of Conflicting Data. NEJM Evid. 2022 Dec; 1(12):EVIDe2200259.
journal title abbreviation: NEJM Evid
publication date: 2022-11-22T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1652065
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.

Authorship 1649320
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.

Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.
PubMed Identifier: 38709212
author list: Bardia A, Sun S, Thimmiah N, Coates JT, Wu B, Abelman RO, Spring L, Moy B, Ryan P, Melkonyan MN, Partridge A, Juric D, Peppercorn J, Parsons H, Wander SA, Attaya V, Lormil B, Shellock M, Nagayama A, Bossuyt V, Isakoff SJ, Tolaney SM, Ellisen LW
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clin Cancer Res. 2024 Jul 15; 30(14):2917-2924.
journal title abbreviation: Clin Cancer Res
publication date: 2024-07-15T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.
PubMed Identifier: 38678525
author list: Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J
published in: Journal of cancer survivorship : research and practice
information resource reference: Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. J Cancer Surviv. 2024 Aug; 18(4):1131-1143.
journal title abbreviation: J Cancer Surviv
publication date: 2024-04-28T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1665197
type: Authorship
author rank in publication: 15
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/245146308

https://connects.catalyst.harvard.edu/Profiles/profile/245146308
PubMed Identifier: 38977064
author list: Freedman RA, Heiling HM, Li T, Trapani D, Tayob N, Smith KL, Davis R, Pereslete AM, DeMeo MK, Cotter C, Chen WY, Parsons HA, Santa-Maria CA, Van Poznak C, Moy B, Brufsky AM, Melisko ME, O'Sullivan CC, Ashai N, Rauf Y, Nangia JR, Burns RT, Savoie J, Wolff AC, Winer EP, Rimawi MF, Krop IE, Lin NU
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022. Ann Oncol. 2024 Nov; 35(11):993-1002.
journal title abbreviation: Ann Oncol
publication date: 2024-07-06T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022.

Authorship 1670432
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers.

Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers.
PubMed Identifier: 39068985
author list: May FP, Brodney S, Tuan JJ, Syngal S, Chan AT, Glenn B, Johnson G, Chang Y, Drew DA, Moy B, Rodriguez NJ, Warner ET, Anyane-Yeboa A, Ukaegbu C, Davis AQ, Schoolcraft K, Regan S, Yoguez N, Kuney S, Le Beaux K, Jeffries C, Lee ET, Bhat R, Haas JS
published in: Contemporary clinical trials
information resource reference: Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers. Contemp Clin Trials. 2024 Oct; 145:107639.
journal title abbreviation: Contemp Clin Trials
publication date: 2024-07-26T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Instructor in Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Instructor in Medicine
position in organization: Massachusetts General Hospital

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 642845
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.

Authorship 665650
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Cancer health disparities and the cost of cancer care: payment model issues.

Authorship 654593
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.

Authorship 658685
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive?

Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
PubMed Identifier: 23775973
author list: Moy B, Bradbury AR, Helft PR, Egleston BL, Sheikh-Salah M, Peppercorn J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Correlation between financial relationships with commercial interests and research prominence at an oncology meeting. J Clin Oncol. 2013 Jul 20; 31(21):2678-84.
journal title abbreviation: J Clin Oncol
publication date: 2013-06-17T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Cancer health disparities and the cost of cancer care: payment model issues.
PubMed Identifier: 23744862
author list: Kumar P, Moy B
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Cancer health disparities and the cost of cancer care: payment model issues. J Natl Compr Canc Netw. 2013 Jun 01; 11(6):633-6.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2013-06-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive?
PubMed Identifier: 23568002
author list: Kumar P, Moy B
published in: The oncologist
information resource reference: The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive? Oncologist. 2013; 18(4):347-9.
journal title abbreviation: Oncologist
publication date: 2013-04-08T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1706190
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations.

Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations.
PubMed Identifier: 39531843
author list: Medford AJ, Moy B
published in: JCO oncology practice
information resource reference: Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations. JCO Oncol Pract. 2024 Nov; 20(11):1515-1522.
journal title abbreviation: JCO Oncol Pract
publication date: 2024-11-12T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 499309
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Lapatinib.

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Massachusetts General Hospital

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
PubMed Identifier: 39774684
author list: Spring LM, Scarpetti L, Medford AJ, Niemierko A, Comander A, Mulvey T, Schnipper L, Isakoff SJ, Moy B, Wander SA, Shin J, Ephrem Z, Laposta AR, Denault E, Abraham E, Calistro G, Kalashnikova E, Rodriguez A, Liu MC, Aleshin A, Peppercorn J, Ellisen LW, Bardia A
published in: NPJ breast cancer
information resource reference: Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER). NPJ Breast Cancer. 2025 Jan 07; 11(1):2.
journal title abbreviation: NPJ Breast Cancer
publication date: 2025-01-07T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
PubMed Identifier: 39745368
author list: Abelman RO, Wu B, Barnes H, Medford A, Norden B, Putur A, Bitman E, Thant W, Liu T, Weipert C, Fell G, Spring LM, Wander SA, Moy B, Vidula N, Isakoff SJ, Varkaris A, Juric D, Corcoran RB, Ellisen LW, Bardia A
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer. Clin Cancer Res. 2025 May 15; 31(10):1966-1974.
journal title abbreviation: Clin Cancer Res
publication date: 2025-05-15T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1717070
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Authorship 1721964
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Authorship 58931
type: Authorship
linked author: Moy, Beverly
linked information resource: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 1725766
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer.

Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer.
PubMed Identifier: 39869305
author list: Sood R, Niemierko A, Ryan L, Spring L, Moy B, Bardia A, Vidula N
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer. Clin Cancer Res. 2025 Apr 01; 31(7):1315-1322.
journal title abbreviation: Clin Cancer Res
publication date: 2025-04-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Medicine, Emeritus
position in organization: Harvard Medical School

Authorship 693924
type: Authorship
author rank in publication: 16
linked author: Moy, Beverly
linked information resource: A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.
PubMed Identifier: 24197661
author list: Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP
published in: Breast cancer research and treatment
information resource reference: A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases. Breast Cancer Res Treat. 2013 Nov; 142(2):405-14.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2013-11-07T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1745819
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies.

Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies.
PubMed Identifier: 40069204
author list: Bar Y, Fell G, Dedeoglu A, Moffett N, Vidula N, Spring L, Wander SA, Bardia A, Ko N, Moy B, Ellisen LW, Isakoff SJ
published in: NPJ breast cancer
information resource reference: Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies. NPJ Breast Cancer. 2025 Mar 11; 11(1):27.
journal title abbreviation: NPJ Breast Cancer
publication date: 2025-03-11T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 702484
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.

Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.
PubMed Identifier: 24409390
author list: Carp SA, Sajjadi AY, Wanyo CM, Fang Q, Specht MC, Schapira L, Moy B, Bardia A, Boas DA, Isakoff SJ
published in: Biomedical optics express
information resource reference: Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system. Biomed Opt Express. 2013; 4(12):2911-24.
journal title abbreviation: Biomed Opt Express
publication date: 2013-11-22T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 419523
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy.

Professor of Surgery
is primary position: true
position in department: Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Surgery
position in organization: Beth Israel Deaconess Medical Center

Authorship 713272
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Massachusetts general hospital: improving patient access to the breast oncology clinic.

Authorship 713716
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/30862204

Authorship 716798
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Ethical considerations for the clinical oncologist in an era of oncology drug shortages.

Authorship 718983
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/30863880

Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
PubMed Identifier: 24449096
author list: Jagsi R, Spence R, Rathmell WK, Bradbury A, Peppercorn J, Grubbs S, Moy B
published in: The oncologist
information resource reference: Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist. 2014 Feb; 19(2):186-92.
journal title abbreviation: Oncologist
publication date: 2014-01-21T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/30862204
PubMed Identifier: 24674874
author list: Moy B, Neven P, Lebrun F, Bellet M, Xu B, Sarosiek T, Chow L, Goss P, Zacharchuk C, Leip E, Turnbull K, Bardy-Bouxin N, Duvillié L, Láng I
published in: The oncologist
information resource reference: Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer. Oncologist. 2014 Apr; 19(4):348-9.
journal title abbreviation: Oncologist
publication date: 2014-03-27T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.

Massachusetts general hospital: improving patient access to the breast oncology clinic.
PubMed Identifier: 24614048
author list: Lennes IT, Bloom M, Bohlen N, Moy B
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Massachusetts general hospital: improving patient access to the breast oncology clinic. J Natl Compr Canc Netw. 2014 Feb; 12 Suppl 1:S25-7.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2014-02-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/30863880
PubMed Identifier: 24674873
author list: Moy B, Neven P, Lebrun F, Bellet M, Xu B, Sarosiek T, Chow L, Goss P, Zacharchuk C, Leip E, Turnbull K, Bardy-Bouxin N, Duvillié L, Láng I
published in: The oncologist
information resource reference: Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer. Oncologist. 2014 Apr; 19(4):346-7.
journal title abbreviation: Oncologist
publication date: 2014-03-27T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.

Authorship 733586
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Value of cancer care: ethical considerations for the practicing oncologist.

Value of cancer care: ethical considerations for the practicing oncologist.
PubMed Identifier: 24857095
author list: Jagsi R, Sulmasy DP, Moy B
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: Value of cancer care: ethical considerations for the practicing oncologist. Am Soc Clin Oncol Educ Book. 2014; e146-9.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2014-01-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 734211
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Core elements of the patient protection and affordable care act and their relevance to the delivery of high-quality cancer care.

Core elements of the patient protection and affordable care act and their relevance to the delivery of high-quality cancer care.
PubMed Identifier: 24451828
author list: Moy B, Abernethy AP, Peppercorn JM
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: Core elements of the patient protection and affordable care act and their relevance to the delivery of high-quality cancer care. Am Soc Clin Oncol Educ Book. 2012; e4-8.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2012-01-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 282590
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.

Authorship 1809883
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Selection biases in the systematic collection of breast biobank specimens.

Authorship 1814589
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Guidance for Community Engagement With Underserved Populations in Cancer Care.

Authorship 1832471
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot study.

Authorship 1832079
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancer.

Authorship 1851164
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Current landscape of sequencing ADCs in metastatic breast cancer.

Selection biases in the systematic collection of breast biobank specimens.
PubMed Identifier: 40750597
author list: Bar Y, Wang GX, Gioia GE, Fell G, Chou SS, Bossuyt V, Isakoff SJ, Moy B, Ellisen LW, Lehman CD, Spring LM
published in: NPJ breast cancer
information resource reference: Selection biases in the systematic collection of breast biobank specimens. NPJ Breast Cancer. 2025 Aug 01; 11(1):83.
journal title abbreviation: NPJ Breast Cancer
publication date: 2025-08-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot study.
PubMed Identifier: 41269378
author list: Post KE, Dunderdale L, Datta S, Varella L, Horick N, Traeger L, Greer JA, Moy B, Temel JS, Jacobs JM
published in: Breast cancer research and treatment
information resource reference: Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot study. Breast Cancer Res Treat. 2025 Nov 21; 215(1):7.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2025-11-21T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancer.
PubMed Identifier: 41172636
author list: Post KE, Dunderdale L, Datta S, Gutierrez N, Varella L, Horick N, Traeger L, Greer JA, Moy B, Temel JS, Jacobs JM
published in: European journal of oncology nursing : the official journal of European Oncology Nursing Society
information resource reference: Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancer. Eur J Oncol Nurs. 2025 Dec; 79:103010.
journal title abbreviation: Eur J Oncol Nurs
publication date: 2025-10-15T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Current landscape of sequencing ADCs in metastatic breast cancer.
PubMed Identifier: 41424607
author list: McLaughlin S, Ravani LV, Moy B, Medford AJ, Isakoff SJ, Liu T, Ellisen LW, Spring LM, Wander SA, Abelman RO
published in: Therapeutic advances in medical oncology
information resource reference: Current landscape of sequencing ADCs in metastatic breast cancer. Ther Adv Med Oncol. 2025; 17:17588359251396656.
journal title abbreviation: Ther Adv Med Oncol
publication date: 2025-12-17T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Guidance for Community Engagement With Underserved Populations in Cancer Care.
PubMed Identifier: 41604605
author list: Solfisburg QS, Vang S, Foster V, Kwon SC, Moy B, Ko NY
published in: JCO oncology practice
information resource reference: Guidance for Community Engagement With Underserved Populations in Cancer Care. JCO Oncol Pract. 2026 Jan 28; OP2501127.
journal title abbreviation: JCO Oncol Pract
publication date: 2026-01-28T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 743538
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

Authorship 744189
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/32699758

https://connects.catalyst.harvard.edu/Profiles/profile/32699758
PubMed Identifier: 23025714
author list: Vaz-Luis I, Ottesen RA, Hughes ME, Marcom PK, Moy B, Rugo HS, Theriault RL, Wilson J, Niland JC, Weeks JC, Lin NU
published in: Breast cancer research : BCR
information resource reference: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study. Breast Cancer Res. 2012 Oct 01; 14(5):R129.
journal title abbreviation: Breast Cancer Res
publication date: 2012-10-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
PubMed Identifier: 24888816
author list: Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, Burstein HJ, Edge SB, Gonzalez-Angulo AM, Moy B, Rugo HS, Theriault RL, Weeks JC, Winer EP, Lin NU
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study. J Clin Oncol. 2014 Jul 10; 32(20):2142-50.
journal title abbreviation: J Clin Oncol
publication date: 2014-06-02T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 751425
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Geriatric oncology for the 21st century: a call for action.

Geriatric oncology for the 21st century: a call for action.
PubMed Identifier: 24781365
author list: Moy B, Flaig TW, Muss HB, Clark B, Tse W, Windham TC
published in: Journal of oncology practice
information resource reference: Geriatric oncology for the 21st century: a call for action. J Oncol Pract. 2014 Jul; 10(4):241-3.
journal title abbreviation: J Oncol Pract
publication date: 2014-04-29T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 348317
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Decision making about surgery for early-stage breast cancer.

Authorship 754560
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy.

Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy.
PubMed Identifier: 25142035
author list: Lee CN, Wetschler MH, Chang Y, Belkora JK, Moy B, Partridge A, Sepucha KR
published in: BMC medical informatics and decision making
information resource reference: Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy. BMC Med Inform Decis Mak. 2014 Aug 20; 14:73.
journal title abbreviation: BMC Med Inform Decis Mak
publication date: 2014-08-20T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 383792
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 761866
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/35122968

https://connects.catalyst.harvard.edu/Profiles/profile/35122968
PubMed Identifier: 25185096
author list: Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014 Oct 10; 32(29):3307-29.
journal title abbreviation: J Clin Oncol
publication date: 2014-09-02T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Peppercorn, Jeffrey
eCommons Login: JMP6
first name: Jeffrey
last name: Peppercorn
full name: Jeffrey Matthew Peppercorn, M.D.
has faculty rank: Associate Professor
Person ID: 57945
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Authorship 434656
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Institutional academic industry relationships.

Authorship 775779
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Debating the oncologist's role in defining the value of cancer care: our duty is to our patients.

Authorship 775536
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: American Society of Clinical Oncology policy statement on medicaid reform.

Debating the oncologist's role in defining the value of cancer care: our duty is to our patients.
PubMed Identifier: 25366686
author list: Sulmasy D, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Debating the oncologist's role in defining the value of cancer care: our duty is to our patients. J Clin Oncol. 2014 Dec 20; 32(36):4039-41.
journal title abbreviation: J Clin Oncol
publication date: 2014-11-03T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

American Society of Clinical Oncology policy statement on medicaid reform.
PubMed Identifier: 25403206
author list: Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: American Society of Clinical Oncology policy statement on medicaid reform. J Clin Oncol. 2014 Dec 20; 32(36):4162-7.
journal title abbreviation: J Clin Oncol
publication date: 2014-11-17T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 777751
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy.

Authorship 778790
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy.
PubMed Identifier: 25564900
author list: Moy B, Specht MC, Lanuti M, Rafferty EA, Lerwill MF
published in: The New England journal of medicine
information resource reference: Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy. N Engl J Med. 2015 Jan 08; 372(2):162-70.
journal title abbreviation: N Engl J Med
publication date: 2015-01-08T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
PubMed Identifier: 25564897
author list: Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Guo H, Hudis CA, Krop IE, Burstein HJ, Winer EP
published in: The New England journal of medicine
information resource reference: Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015 Jan 08; 372(2):134-41.
journal title abbreviation: N Engl J Med
publication date: 2015-01-08T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 536739
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Ethical challenges: caring for the underinsured, geographically disadvantaged patient.

Authorship 367298
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women.

Authorship 346557
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Lapatinib-associated toxicity and practical management recommendations.

Authorship 294152
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery.

Authorship 19724
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.

Authorship 418591
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib.

Authorship 471969
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.

Authorship 514643
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/858070

Authorship 481887
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.

Authorship 791392
type: Authorship
author rank in publication: 11
linked author: Moy, Beverly
linked information resource: Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Authorship 796380
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: The impact of industry on oncology research and practice.

Authorship 801233
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

Authorship 803248
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.

Authorship 794234
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

Authorship 793266
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

Authorship 806336
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.

Authorship 804596
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Clinical Trials, Disparities, and Financial Burden: It's Time to Intervene.

Recognizing the Financial Burden of Cancer Patients in Clinical Trials.
PubMed Identifier: 25986245
author list: Nipp RD, Powell E, Chabner B, Moy B
published in: The oncologist
information resource reference: Recognizing the Financial Burden of Cancer Patients in Clinical Trials. Oncologist. 2015 Jun; 20(6):572-5.
journal title abbreviation: Oncologist
publication date: 2015-05-18T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
PubMed Identifier: 25752740
author list: Boyle FM, Smith IE, O'Shaughnessy J, Ejlertsen B, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Amonkar M, Huang Y, Rappold E, Williams LS, Wang-Silvanto J, Kaneko T, Finkelstein DM, Goss PE
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer. 2015 Apr; 51(6):685-96.
journal title abbreviation: Eur J Cancer
publication date: 2015-03-06T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical Trials, Disparities, and Financial Burden: It's Time to Intervene.
PubMed Identifier: 25986242
author list: Moy B
published in: The oncologist
information resource reference: Clinical Trials, Disparities, and Financial Burden: It's Time to Intervene. Oncologist. 2015 Jun; 20(6):571.
journal title abbreviation: Oncologist
publication date: 2015-05-18T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.
PubMed Identifier: 25757412
author list: Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU
published in: Cancer
information resource reference: Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study. Cancer. 2015 Jun 15; 121(12):1937-48.
journal title abbreviation: Cancer
publication date: 2015-03-10T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
PubMed Identifier: 25534386
author list: Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, Stockerl-Goldstein K, Neumayer L, Langbaum TS, Theriault RL, Hughes ME, Weeks JC, Karp JE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience. J Clin Oncol. 2015 Feb 01; 33(4):340-8.
journal title abbreviation: J Clin Oncol
publication date: 2014-12-22T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
PubMed Identifier: 25981899
author list: Ruddy KJ, Guo H, Barry W, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Hudis C, Krop IE, Burstein HJ, Winer EP, Partridge AH, Tolaney SM
published in: Breast cancer research and treatment
information resource reference: Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Breast Cancer Res Treat. 2015 Jun; 151(3):589-96.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2015-05-16T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
PubMed Identifier: 25888246
author list: Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
published in: Breast cancer research : BCR
information resource reference: Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Res. 2015 Apr 16; 17:56.
journal title abbreviation: Breast Cancer Res
publication date: 2015-04-16T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

The impact of industry on oncology research and practice.
PubMed Identifier: 25993151
author list: Moy B, Jagsi R, Gaynor RB, Ratain MJ
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: The impact of industry on oncology research and practice. Am Soc Clin Oncol Educ Book. 2015; 130-7.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2015-01-01T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 818294
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Interaction of CC-1065 and its analogues with mouse DNA and chromatin.

Authorship 818702
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.

Interaction of CC-1065 and its analogues with mouse DNA and chromatin.
PubMed Identifier: 2702639
author list: Moy BC, Prairie MD, Krueger WC, Bhuyan BK
published in: Cancer research
information resource reference: Interaction of CC-1065 and its analogues with mouse DNA and chromatin. Cancer Res. 1989 Apr 15; 49(8):1983-8.
journal title abbreviation: Cancer Res
publication date: 1989-04-15T00:00:00
year: 1989
type: Academic Article
type: Article
type: Document
type: Information Resource

Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
PubMed Identifier: 2317831
author list: Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, Li LH, Bhuyan BK
published in: Cancer research
information resource reference: Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184. Cancer Res. 1990 Apr 15; 50(8):2485-92.
journal title abbreviation: Cancer Res
publication date: 1990-04-15T00:00:00
year: 1990
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 840100
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.
PubMed Identifier: 26461004
author list: Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS
published in: International journal of radiation oncology, biology, physics
information resource reference: Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):622-30.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2015-07-11T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 443815
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Patient navigation for underserved patients diagnosed with breast cancer.

Authorship 844750
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
PubMed Identifier: 26371147
author list: Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, Isakoff S, Ellisen LW, Bardia A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence. J Clin Oncol. 2015 Nov 01; 33(31):3621-7.
journal title abbreviation: J Clin Oncol
publication date: 2015-09-14T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 860751
type: Authorship
author rank in publication: 13
linked author: Moy, Beverly
linked information resource: Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

Authorship 859331
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.

Authorship 858332
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Announcing a New Journal Section: Community Outreach.

Announcing a New Journal Section: Community Outreach.
PubMed Identifier: 26712959
author list: Evans M, Moy B
published in: The oncologist
information resource reference: Announcing a New Journal Section: Community Outreach. Oncologist. 2016 Jan; 21(1):1.
journal title abbreviation: Oncologist
publication date: 2015-12-28T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
PubMed Identifier: 2145026
author list: Badiner GJ, Moy BC, Smith KS, Tarpley WG, Groppi VE, Bhuyan BK
published in: British journal of cancer
information resource reference: P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype. Br J Cancer. 1990 Sep; 62(3):378-84.
journal title abbreviation: Br J Cancer
publication date: 1990-09-01T00:00:00
year: 1990
type: Academic Article
type: Article
type: Document
type: Information Resource

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
PubMed Identifier: 26539793
author list: Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM
published in: JAMA oncology
information resource reference: Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncol. 2016 Jan; 2(1):29-36.
journal title abbreviation: JAMA Oncol
publication date: 2016-01-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 865493
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.

Authorship 865410
type: Authorship
author rank in publication: 11
linked author: Moy, Beverly
linked information resource: Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

Authorship 866155
type: Authorship
author rank in publication: 12
linked author: Moy, Beverly
linked information resource: Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
PubMed Identifier: 26834058
author list: Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, Agar NY, Ryabin N, Farooq S, Lawler E, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. J Clin Oncol. 2016 Mar 20; 34(9):945-52.
journal title abbreviation: J Clin Oncol
publication date: 2016-02-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.
PubMed Identifier: 26829011
author list: Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. Eur J Cancer. 2016 Mar; 56:85-92.
journal title abbreviation: Eur J Cancer
publication date: 2016-01-30T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.
PubMed Identifier: 26868124
author list: Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU
published in: Breast cancer research and treatment
information resource reference: Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat. 2016 Feb; 155(3):569-78.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2016-02-11T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 872201
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
PubMed Identifier: 26874901
author list: Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SKL, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M
published in: The Lancet. Oncology
information resource reference: Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2016 Mar; 17(3):367-377.
journal title abbreviation: Lancet Oncol
publication date: 2016-02-10T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
PubMed Identifier: 26975867
author list: Nipp RD, Lee H, Powell E, Birrer NE, Poles E, Finkelstein D, Winkfield K, Percac-Lima S, Chabner B, Moy B
published in: The oncologist
information resource reference: Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. Oncologist. 2016 Apr; 21(4):467-74.
journal title abbreviation: Oncologist
publication date: 2016-03-14T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 877201
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authorship 884909
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications.

Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications.
PubMed Identifier: 27249727
author list: Melisko ME, Gradishar WJ, Moy B
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications. Am Soc Clin Oncol Educ Book. 2016; 35:e22-9.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2016-01-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Instructor
sort order: 4
type: Faculty Rank

Medford, Arielle
eCommons Login: AJM80
first name: Arielle
last name: Medford
full name: Arielle Janine Medford, M.D.
has faculty rank: Instructor
Person ID: 150708
person in primary position: Instructor in Medicine
type: Agent
type: Person
preferred title: Instructor in Medicine

Authorship 891857
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.

Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.
PubMed Identifier: 27389914
author list: Marshall DC, Moy B, Jackson ME, Mackey TK, Hattangadi-Gluth JA
published in: Journal of the National Cancer Institute
information resource reference: Distribution and Patterns of Industry-Related Payments to Oncologists in 2014. J Natl Cancer Inst. 2016 12; 108(12).
journal title abbreviation: J Natl Cancer Inst
publication date: 2016-07-07T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 94460
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Lapatinib: current status and future directions in breast cancer.

Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
PubMed Identifier: 27367583
author list: Spring LM, Gupta A, Reynolds KL, Gadd MA, Ellisen LW, Isakoff SJ, Moy B, Bardia A
published in: JAMA oncology
information resource reference: Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2016 Nov 01; 2(11):1477-1486.
journal title abbreviation: JAMA Oncol
publication date: 2016-11-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 933637
type: Authorship
author rank in publication: 7
linked author: Moy, Beverly
linked information resource: Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.

Authorship 930929
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting?

The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting?
PubMed Identifier: 27821795
author list: Jackson JD, Moy B, Evans MK
published in: The oncologist
information resource reference: The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting? Oncologist. 2016 12; 21(12):1411-1413.
journal title abbreviation: Oncologist
publication date: 2016-11-07T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

55 Fruit St
type: Address
address line 1: Massachusetts General Hospital
address line 2: Gillette Ctr for Breast Cancer, YAW 9A
address line 3: 55 Fruit St
city: Boston
postal code: 02114
state or province: MA

Authorship 939916
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: No Conflict, No Interest.

No Conflict, No Interest.
PubMed Identifier: 27560041
author list: Nipp RD, Moy B
published in: JAMA oncology
information resource reference: No Conflict, No Interest. JAMA Oncol. 2016 Dec 01; 2(12):1631-1632.
journal title abbreviation: JAMA Oncol
publication date: 2016-12-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 941300
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Hepatobiliary abnormalities in patients with metastatic cancer treated with lapatinib.

Authorship 942678
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: NCIC CTG MA.17: Tolerability of letrozole among ethnic minority women.

Authorship 943893
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.

NCIC CTG MA.17: Tolerability of letrozole among ethnic minority women.
PubMed Identifier: 27954595
author list: Moy B, Tu D, Shepherd LE, Pater JL, Whelan TJ, Ingle JN, Goss PE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: NCIC CTG MA.17: Tolerability of letrozole among ethnic minority women. J Clin Oncol. 2006 Jun 20; 24(18_suppl):6018.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Hepatobiliary abnormalities in patients with metastatic cancer treated with lapatinib.
PubMed Identifier: 27961107
author list: Moy B, Rappold E, Williams L, Kelly T, Nicolodi L, Maltzman JD, Goss PE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hepatobiliary abnormalities in patients with metastatic cancer treated with lapatinib. J Clin Oncol. 2009 May 20; 27(15_suppl):1043.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.
PubMed Identifier: 27958134
author list: Carp SA, Wanyo C, Specht MC, Schapira L, Moy B, Finkelstein DM, Boas D, Isakoff SJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 Sep 20; 29(27_suppl):60.
journal title abbreviation: J Clin Oncol
publication date: 2011-09-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 945419
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC).

Authorship 945405
type: Authorship
author rank in publication: 4
linked author: Moy, Beverly
linked information resource: Bosutinib (BOS) and letrozole (LET) versus LET alone as first-line treatment in postmenopausal women with advanced breast cancer (ABC).

Authorship 945404
type: Authorship
author rank in publication: 1
linked author: Moy, Beverly
linked information resource: Bosutinib and exemestane (EXE) versus EXE alone in postmenopausal (postm) women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (ABC).

Authorship 945062
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.

A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC).
PubMed Identifier: 28022891
author list: Goss PE, Barrios CH, Chan A, Chia SK, Delaloge S, Ejlertsen B, Ingle JN, Moy B, Iwata H, Holmes FA, Mansi J, Von Minckwitz G, Han L, Thiele A, Agrapart V, Freyman A, Truscello J, Berkenblit A, Finkelstein D
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS137.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Bosutinib (BOS) and letrozole (LET) versus LET alone as first-line treatment in postmenopausal women with advanced breast cancer (ABC).
PubMed Identifier: 28020644
author list: Chow L, Xu B, Dirix LY, Moy B, Leip E, Bardy-Bouxin N, Duvillie L, Sarosiek T
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Bosutinib (BOS) and letrozole (LET) versus LET alone as first-line treatment in postmenopausal women with advanced breast cancer (ABC). J Clin Oncol. 2011 May 20; 29(15_suppl):614.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.
PubMed Identifier: 28022835
author list: Carp SA, Wanyo C, Specht M, Schapira L, Moy B, Finkelstein D, Boas D, Isakoff SJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):10607.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Bosutinib and exemestane (EXE) versus EXE alone in postmenopausal (postm) women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (ABC).
PubMed Identifier: 28020590
author list: Moy B, Lebrun F, Bellet M, Chow L, Lang I, Xu B, Badwe RA, Hershman DL, Leip E, Bardy-Bouxin N, Duvillie L, Neven P
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Bosutinib and exemestane (EXE) versus EXE alone in postmenopausal (postm) women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (ABC). J Clin Oncol. 2011 May 20; 29(15_suppl):631.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 954713
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Neoadjuvant single and dual HER2 blockade among patients with localized HER2-positive breast cancer.

Authorship 955247
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/72396086

Authorship 953540
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.

Authorship 954126
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/72396276

Authorship 954890
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Palliative care consultation for patients enrolled in cancer clinical trials.

Authorship 953557
type: Authorship
author rank in publication: 6
linked author: Moy, Beverly
linked information resource: Alleviating financial burden for cancer patients in clinical trials.

Authorship 955217
type: Authorship
author rank in publication: 2
linked author: Moy, Beverly
linked information resource: Hospitalizations and emergency department use in cancer clinical trial patients.

Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.
PubMed Identifier: 28136532
author list: Juric D, Isakoff SJ, Borger DR, Dias-Santagata D, Higgins MJ, Iafrate AJ, Flaherty K, Moy B, Ellisen LW
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review. J Clin Oncol. 2013 Sep 10; 31(26_suppl):145.
journal title abbreviation: J Clin Oncol
publication date: 2013-09-10T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/72396086
PubMed Identifier: 28136572
author list: Morris PG, Patil S, Chen C, Abbruzzi A, Lehman RJ, Steingart R, Oeffinger KC, Lin NU, Moy B, Come SE, Winer EP, Norton L, Hudis C, Dang CT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC). J Clin Oncol. 2013 Sep 10; 31(26_suppl):167.
journal title abbreviation: J Clin Oncol
publication date: 2013-09-10T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC).

Alleviating financial burden for cancer patients in clinical trials.
PubMed Identifier: 28141479
author list: Powell E, Finkelstein D, Winkfield KM, Percac-Lima S, Chabner BA, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Alleviating financial burden for cancer patients in clinical trials. J Clin Oncol. 2014 Oct 20; 32(30_suppl):10.
journal title abbreviation: J Clin Oncol
publication date: 2014-10-20T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/72396276
PubMed Identifier: 28147820
author list: Martin M, Von Minckwitz G, Ejlertsen B, Chia SK, Buyse ME, Mansi J, Gnant M, Holmes FA, Moy B, Iwata H, Wong A, Lalani AS, Bryce R, Bebchuk JD, Delaloge S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Invasive disease-free survival benefit following neratinib as extended adjuvant therapy in centrally-confirmed HER2+ early-stage breast cancer: The ExteNET phase III randomized placebo-controlled trial. J Clin Oncol. 2015 Oct; 33(28_suppl):117.
journal title abbreviation: J Clin Oncol
publication date: 2015-10-01T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Invasive disease-free survival benefit following neratinib as extended adjuvant therapy in centrally-confirmed HER2+ early-stage breast cancer: The ExteNET phase III randomized placebo-controlled trial.

Hospitalizations and emergency department use in cancer clinical trial patients.
PubMed Identifier: 28147984
author list: Powell E, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hospitalizations and emergency department use in cancer clinical trial patients. J Clin Oncol. 2015 Oct 10; 33(29_suppl):160.
journal title abbreviation: J Clin Oncol
publication date: 2015-10-10T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Palliative care consultation for patients enrolled in cancer clinical trials.
PubMed Identifier: 28148062
author list: Powell E, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Palliative care consultation for patients enrolled in cancer clinical trials. J Clin Oncol. 2015 Oct 10; 33(29_suppl):139.
journal title abbreviation: J Clin Oncol
publication date: 2015-10-10T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Neoadjuvant single and dual HER2 blockade among patients with localized HER2-positive breast cancer.
PubMed Identifier: 28136533
author list: Cheng X, Bhatia A, Specht MC, Smith BL, Moy B, Bardia A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Neoadjuvant single and dual HER2 blockade among patients with localized HER2-positive breast cancer. J Clin Oncol. 2013 Sep 10; 31(26_suppl):147.
journal title abbreviation: J Clin Oncol
publication date: 2013-09-10T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
PubMed Identifier: 16293865
author list: Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005 Nov 20; 23(33):8340-7.
journal title abbreviation: J Clin Oncol
publication date: 2005-11-20T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 968348
type: Authorship
author rank in publication: 9
linked author: Moy, Beverly
linked information resource: Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).

Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).
PubMed Identifier: 28270967
author list: Sajjadi AY, Isakoff SJ, Deng B, Singh B, Wanyo CM, Fang Q, Specht MC, Schapira L, Moy B, Bardia A, Boas DA, Carp SA
published in: Biomedical optics express
information resource reference: Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI). Biomed Opt Express. 2017 Feb 01; 8(2):555-569.
journal title abbreviation: Biomed Opt Express
publication date: 2017-01-04T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17525937
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10).
journal title abbreviation: Psychooncology
publication date: 2007-05-24T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 973535
type: Authorship
author rank in publication: 8
linked author: Moy, Beverly
linked information resource: A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
PubMed Identifier: 28324268
author list: Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS
published in: Breast cancer research and treatment
information resource reference: A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2017 06; 163(3):535-544.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2017-03-21T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.
PubMed Identifier: 16914563
author list: Moy B, Goss PE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches. Clin Cancer Res. 2006 Aug 15; 12(16):4790-3.
journal title abbreviation: Clin Cancer Res
publication date: 2006-08-15T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Doctor-patient communication about advance directives in metastatic breast cancer.
PubMed Identifier: 19508141
author list: Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR
published in: Journal of palliative medicine
information resource reference: Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53.
journal title abbreviation: J Palliat Med
publication date: 2009-06-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Lapatinib: current status and future directions in breast cancer.
PubMed Identifier: 17110623
author list: Moy B, Goss PE
published in: The oncologist
information resource reference: Lapatinib: current status and future directions in breast cancer. Oncologist. 2006 Nov-Dec; 11(10):1047-57.
journal title abbreviation: Oncologist
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 988922
type: Authorship
author rank in publication: 10
linked author: Moy, Beverly
linked information resource: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.
PubMed Identifier: 28618241
author list: Dhesy-Thind S, Fletcher GG, Blanchette PS, Clemons MJ, Dillmon MS, Frank ES, Gandhi S, Gupta R, Mates M, Moy B, Vandenberg T, Van Poznak CH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017 Jun 20; 35(18):2062-2081.
journal title abbreviation: J Clin Oncol
publication date: 2017-03-06T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17245695
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903.
journal title abbreviation: Psychooncology
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
PubMed Identifier: 23234763
author list: Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM
published in: The Lancet. Oncology
information resource reference: Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Jan; 14(1):88-96.
journal title abbreviation: Lancet Oncol
publication date: 2012-12-10T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 995241
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.
PubMed Identifier: 28706010
author list: Spring LM, Zangardi ML, Moy B, Bardia A
published in: The oncologist
information resource reference: Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Oncologist. 2017 09; 22(9):1039-1048.
journal title abbreviation: Oncologist
publication date: 2017-07-13T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Institutional academic industry relationship: results of interviews with university leaders.
PubMed Identifier: 15675051
author list: Campbell EG, Moy B, Feibelmann S, Weissman JS, Blumenthal D
published in: Accountability in research
information resource reference: Institutional academic industry relationship: results of interviews with university leaders. Account Res. 2004 Apr-Jun; 11(2):103-18.
journal title abbreviation: Account Res
publication date: 2004-04-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Institutional academic industry relationships.
PubMed Identifier: 17940234
author list: Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD
published in: JAMA
information resource reference: Institutional academic industry relationships. JAMA. 2007 Oct 17; 298(15):1779-86.
journal title abbreviation: JAMA
publication date: 2007-10-17T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/858070
PubMed Identifier: 20479410
author list: Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea. J Clin Oncol. 2010 Jun 20; 28(18):2982-8.
journal title abbreviation: J Clin Oncol
publication date: 2010-05-17T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea.

Ethical challenges: caring for the underinsured, geographically disadvantaged patient.
PubMed Identifier: 23180985
author list: Riley EC, Moy B
published in: Journal of oncology practice
information resource reference: Ethical challenges: caring for the underinsured, geographically disadvantaged patient. J Oncol Pract. 2012 Jul; 8(4):215-8.
journal title abbreviation: J Oncol Pract
publication date: 2012-07-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy.
PubMed Identifier: 18515732
author list: Moy B
published in: The oncologist
information resource reference: Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy. Oncologist. 2008 May; 13(5):474-6.
journal title abbreviation: Oncologist
publication date: 2008-05-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Decision making about surgery for early-stage breast cancer.
PubMed Identifier: 22056355
author list: Lee CN, Chang Y, Adimorah N, Belkora JK, Moy B, Partridge AH, Ollila DW, Sepucha KR
published in: Journal of the American College of Surgeons
information resource reference: Decision making about surgery for early-stage breast cancer. J Am Coll Surg. 2012 Jan; 214(1):1-10.
journal title abbreviation: J Am Coll Surg
publication date: 2011-11-06T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women.
PubMed Identifier: 16304623
author list: Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS
published in: Psycho-oncology
information resource reference: Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women. Psychooncology. 2006 Jul; 15(7):623-34.
journal title abbreviation: Psychooncology
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].
PubMed Identifier: 21200195
author list: Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K
published in: Plastic and reconstructive surgery
information resource reference: Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article]. Plast Reconstr Surg. 2011 Jan; 127(1):18-26.
journal title abbreviation: Plast Reconstr Surg
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1016399
type: Authorship
author rank in publication: 14
linked author: Moy, Beverly
linked information resource: Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.
PubMed Identifier: 28982747
author list: Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. J Natl Compr Canc Netw. 2017 10; 15(10):1216-1223.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2017-10-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1018949
type: Authorship
author rank in publication: 3
linked author: Moy, Beverly
linked information resource: Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary.

Authorship 1019489
type: Authorship
author rank in publication: 16
linked author: Moy, Beverly
linked information resource: Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary.
PubMed Identifier: 29035617
author list: Van Poznak C, Somerfield MR, Moy B
published in: Journal of oncology practice
information resource reference: Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary. J Oncol Pract. 2017 12; 13(12):822-824.
journal title abbreviation: J Oncol Pract
publication date: 2017-10-16T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.
PubMed Identifier: 29035643
author list: Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, Dhesy-Thind SK, Dillmon MS, Eisen A, Frank ES, Jagsi R, Jimenez R, Theriault RL, Vandenberg TA, Yee GC, Moy B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. J Clin Oncol. 2017 Dec 10; 35(35):3978-3986.
journal title abbreviation: J Clin Oncol
publication date: 2017-10-16T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
PubMed Identifier: 15274062
author list: Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, Kaine EM, Moore RH, Halpern EF, Hughes KS, Tanabe KK, Smith BL, Michaelson JS
published in: Cancer
information resource reference: Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer. 2004 Aug 01; 101(3):495-507.
journal title abbreviation: Cancer
publication date: 2004-08-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1026397
type: Authorship
author rank in publication: 5
linked author: Moy, Beverly
linked information resource: Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
PubMed Identifier: 29146401
author list: Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomaševic Z, Denduluri N, Šeparovic R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A
published in: The Lancet. Oncology
information resource reference: Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2017 12; 18(12):1688-1700.
journal title abbreviation: Lancet Oncol
publication date: 2017-11-13T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.
PubMed Identifier: 16936184
author list: Moy B, Tu D, Pater JL, Ingle JN, Shepherd LE, Whelan TJ, Goss PE
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer. Ann Oncol. 2006 Nov; 17(11):1637-43.
journal title abbreviation: Ann Oncol
publication date: 2006-08-25T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Is there a role for decision aids in advanced breast cancer?
PubMed Identifier: 19329775
author list: Sepucha KR, Ozanne EM, Partridge AH, Moy B
published in: Medical decision making : an international journal of the Society for Medical Decision Making
information resource reference: Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82.
journal title abbreviation: Med Decis Making
publication date: 2009-03-27T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
PubMed Identifier: 19901120
author list: Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction. J Clin Oncol. 2009 Dec 20; 27(36):6117-23.
journal title abbreviation: J Clin Oncol
publication date: 2009-11-09T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient navigation for underserved patients diagnosed with breast cancer.
PubMed Identifier: 22752069
author list: Raj A, Ko N, Battaglia TA, Chabner BA, Moy B
published in: The oncologist
information resource reference: Patient navigation for underserved patients diagnosed with breast cancer. Oncologist. 2012; 17(8):1027-31.
journal title abbreviation: Oncologist
publication date: 2012-07-02T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Hemolytic uremic syndrome associated with clopidogrel: a case report.
PubMed Identifier: 10809043
author list: Moy B, Wang JC, Raffel GD, Marcoux JP
published in: Archives of internal medicine
information resource reference: Hemolytic uremic syndrome associated with clopidogrel: a case report. Arch Intern Med. 2000 May 08; 160(9):1370-2.
journal title abbreviation: Arch Intern Med
publication date: 2000-05-08T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource